Patent 7135610 was granted and assigned to Riken on November, 2006 by the United States Patent and Trademark Office.
A transgenic mouse transformed with a DNA encoding a mutant human tau protein, wherein the mouse exhibits neurofibrillary tangles in its brain. The transgenic mouse is useful for the development of the agent for treating neurodegenerative disorders such as Alzheimer's disease.